Submitted references Synthesis and evaluation of novel potent TSPO PET ligands with 2-phenylpyrazolo[1,5-a]pyrimidin-3-yl acetamide.
Hieu Tran V, Park H, Park J, Kwon YD, Kang S, Ho Jung J, Chang KA, Chul Lee B, Lee SY, Kang S, Kim HK
Bioorganic & medicinal chemistry 2019 Sep 15;27(18):4069-4080
Preclinical TSPO Ligand PET to Visualize Human Glioma Xenotransplants: A Preliminary Study.
Buck JR, McKinley ET, Fu A, Abel TW, Thompson RC, Chambless L, Watchmaker JM, Harty JP, Cooper MK, Manning HC
PloS one 2015;10(10):e0141659
ERManI (Endoplasmic Reticulum Class I α-Mannosidase) Is Required for HIV-1 Envelope Glycoprotein Degradation via Endoplasmic Reticulum-associated Protein Degradation Pathway.
Zhou T, Frabutt DA, Moremen KW, Zheng YH
The Journal of biological chemistry 2015 Sep 4;290(36):22184-92
The mitochondrial translocator protein, TSPO, inhibits HIV-1 envelope glycoprotein biosynthesis via the endoplasmic reticulum-associated protein degradation pathway.
Zhou T, Dang Y, Zheng YH
Journal of virology 2014 Mar;88(6):3474-84
The 18-kDa translocator protein (TSPO) disrupts mammary epithelial morphogenesis and promotes breast cancer cell migration.
Wu X, Gallo KA
PloS one 2013;8(8):e71258
Peripheral benzodiazepine receptor regulates vascular endothelial activations via suppression of the voltage-dependent anion channel-1.
Joo HK, Lee YR, Lim SY, Lee EJ, Choi S, Cho EJ, Park MS, Ryoo S, Park JB, Jeon BH
FEBS letters 2012 May 7;586(9):1349-55
Translocator protein blockade reduces prostate tumor growth.
Fafalios A, Akhavan A, Parwani AV, Bies RR, McHugh KJ, Pflug BR
Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Oct 1;15(19):6177-84
Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function.
Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapère JJ, Lindemann P, Norenberg MD, Nutt D, Weizman A, Zhang MR, Gavish M
Trends in pharmacological sciences 2006 Aug;27(8):402-9